Racial Variations in Treatment and Outcomes of Black and White Patients With High-Risk Non–ST-Elevation Acute Coronary Syndromes
Open Access
- 15 March 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 111 (10), 1225-1232
- https://doi.org/10.1161/01.cir.0000157732.03358.64
Abstract
Background— Black patients with acute myocardial infarction are less likely than whites to receive coronary interventions. It is unknown whether racial disparities exist for other treatments for non–ST-segment elevation acute coronary syndromes (NSTE ACS) and how different treatments affect outcomes. Methods and Results— Using data from 400 US hospitals participating in the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines?) National Quality Improvement Initiative, we identified black and white patients with high-risk NSTE ACS (positive cardiac markers and/or ischemic ST-segment changes). After adjustment for demographics and medical comorbidity, we compared the use of therapies recommended by the American College of Cardiology/American Heart Association guidelines for NSTE ACS and outcomes by race. Our study included 37 813 (87.3%) white and 5504 (12.7%) black patients. Black patients were younger; were more likely to have hypertension, diabetes, heart failure, and renal insufficiency; and were less likely to have insurance coverage or primary cardiology care. Black patients had a similar or higher likelihood than whites of receiving older ACS treatments such as aspirin, β-blockers, or ACE inhibitors but were significantly less likely to receive newer ACS therapies, including acute glycoprotein IIb/IIIa inhibitors, acute and discharge clopidogrel, and statin therapy at discharge. Blacks were also less likely to receive cardiac catheterization, revascularization procedures, or smoking cessation counseling. Acute risk-adjusted outcomes were similar between black and white patients. Conclusions— Black patients with NSTE ACS were less likely than whites to receive many evidence-based treatments, particularly those that are costly or newer. Longitudinal studies are needed to assess the long-term impact of these treatment disparities on clinical outcomes.This publication has 44 references indexed in Scilit:
- Evidence-Based Therapies for Myocardial Infarction: Secular Trends and Determinants of Practice in the CommunityMayo Clinic Proceedings, 2004
- Regional variation in the treatment and outcomes of myocardial infarction: investigating New England’s advantageAmerican Heart Journal, 2003
- Early use of glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute myocardial infarctionJournal of the American College of Cardiology, 2003
- Improving the Care of Patients with Non‐ST‐elevation Acute Coronary Syndromes in the Emergency Department: The CRUSADE InitiativeAcademic Emergency Medicine, 2002
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)Journal of the American College of Cardiology, 2000
- The Effect of Patients' Preferences on Racial Differences in Access to Renal TransplantationThe New England Journal of Medicine, 1999
- Effects of Socioeconomic Status on Access to Invasive Cardiac Procedures and on Mortality after Acute Myocardial InfarctionThe New England Journal of Medicine, 1999
- Management and outcomes for black patients with acute myocardial infarction in the reperfusion eraThe American Journal of Cardiology, 1998
- Racial Differences in the Use of Invasive Cardiovascular Procedures in the Department of Veterans Affairs Medical SystemThe New England Journal of Medicine, 1993
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986